Jeffrey Donohue
Corporate Officer/Principal at Novartis Institutes for Biomedical Research, Inc.
Profile
Jeffrey Donohue is currently working as a Corporate Counsel at Novartis Institutes for Biomedical Research, Inc. He previously worked as an Independent Non-Executive Director at Spectra Systems Corp.
from 2012 to 2016.
He has a graduate degree from Boston University and an undergraduate degree from Brandeis University.
Jeffrey Donohue active positions
Companies | Position | Start |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Former positions of Jeffrey Donohue
Companies | Position | End |
---|---|---|
SPECTRA SYSTEMS CORPORATION | Director/Board Member | 30/05/2016 |
Training of Jeffrey Donohue
Boston University | Graduate Degree |
Brandeis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPECTRA SYSTEMS CORPORATION | Electronic Technology |
Private companies | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Jeffrey Donohue